3rd Edition of
International Ophthalmology Conference
March 10-12, 2025 | Rome, Italy
Neuro-Ophthalmology
Having superior eyesight makes it easier to complete daily duties. However, eyesight problems are a prevalent issue. Both neurology and ophthalmology have a specialization called neuro-ophthalmology. Neuro ophthalmologists are eye doctors who specialize on visual issues caused by the neurological system. A neuro-ophthalmologist is a doctor that specializes in the diagnosis and treatment of neurological and systemic illnesses that impact your vision and eye movement. Although some of the disorders observed by neuro-ophthalmologists are not life threatening, others might progress and cause irreversible vision loss or even death. The problem may be limited to the optic nerve or neurological system, or it may be related to a more general medical disease.
- Neurologic and Ophthalmologic Sciences
- Diagnosing and Treating
- Neoplastic Conditions Affecting the Oculomotor and Visual Systems
John David Bullock
Wright State University, United States
Minckler Don S
UCI Gavin Herbert Eye Institute, United States
Kasra Rezaei
University of Washington, United States
Dhruva Drew Gupta
Harvard Medical School, United States
Nour Abou Shousha
Harvard Medical School, United States
George HH Beiko
McMaster Univeresity, Canada
Mustafa Al Ghazi
University Hospital of Wales, United KingdomSubmit your abstract Today
Title : Optic nerve orthograde axonal transport in abusive head trauma suspects
Minckler Don S, UCI Gavin Herbert Eye Institute, United States
Title : Eyes and guts connection: Microbiomes and their role in ocular health
Edward Charles Kondrot, Healing the Eye Wellness Center, United States
Title : Ultra-Widefield protocol enhances automated classification of diabetic retinopathy severity with OCT angiography
Kasra Rezaei, University of Washington, United States
Title : Why was Leonhard Euler blind?
John David Bullock, Wright State University, United States
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Developing resilience-based treatments for glaucoma
Simon John, Columbia University, United States